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Synergistic effects of calcium-mobilizing agents and 
adenosine on histamine release from rat peritoneal 
mast cells 
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1 Adenosine and its metabolically stable analogue N.etbyl-carboxamidoadenosine (NECA) 
enhance histamine release from rat peritoneal mast cells when tbese are stimulated by calcium-
mobilizing agents. NECA and adenosine shift the concentration-response curve of tbe calcium ion-
ophore A23187 to lower concentrations. 
2 The potencies of NECA or adenosinein enhancing A23187-induced histamine release are depen-
dent on the Ievel of stimulated release in tbe absence of adenosine analogues. At high Ievels of 
release their potencies are up to 20 times higher than at low Ievels. Consequently, averaged 
concentration-response curves of adenosine and NECA for enhancing bistamine release are shallow. 
3 The adenosine transport blocker S-(p-nitrobenzyl)-6-thioinosine (NBTI) has no effect by itself at 
low Ievels of stimulated histamine release, but abolishes the enhancing effect of adenosine. At high 
Ievels of release, however, NBTI alone enhances the release of histamine. 
4 lt is concluded that adenosine and calcium reciprocally enhance the sensitivity of the secretory 
processes to the effects of the other agent. The Ievels of intracellular adenosine obtained by trapping 
adenosine inside stimulated mast cells are sufficient to enhance histamine release substantially, sug-
gesting that this effect may play a physiological and pathophysiological role. 
lntrocluction 
Mast cells release histamine and other mediators of 
allergy in response to a variety of lgE-directed 
stimuli. The release is generally thought to be inti-
mately related to an elevation of free cytosolic 
calcium (Foreman, 1980) which increases upon lgE-
receptor stimulation (White et al., 1984). Tbis 
increase of free intracellular calcium Ievels appears to 
be mediated by generation of inositol-trisphosphate 
(Beaven et al., 1984; Nakamura & Ui, 1985). In vitro, 
release can also be initiated by the calcium-
ionophore A23187, which causes a direct increase of 
cytosolic calcium (Foreman, 1980). 
However, there is increasing evidence that an ele-
vation of intracellular calcium within the physiologi-
cal range is not sußicient to trigger mast cell 
mediator release (Neher & Almers, 1986). Conse-
quently, additional signalling pathways have been 
postulated that act in concert with intracellular 
calcium (Beaven et al., 1987; Penner & Neher, 1988; 
Penner, 1988). In a recent study we identified aden-
osine as a candidate for such a pathway which acts 
1 Author for correspondence. 
by increasing the calcium-sensitivity of the release 
process (Lohse et al., 1988). 
Adenosine has been known for several years to 
enhance mediator release from different types of 
mast cells (Marquardt et al., 1978; Welton & Simko, 
1980). Whereas earlier studies showed that the 
stimulation of mast cell mediator release by aden-
osine is antagonized by the adenosine receptor 
antagonist theophylline (Marquardt et al., 1978; 
Church et al., 1983; Hughes et al., 1984), more recent 
studies have failed to confirm this observation 
(Vardey & Skidmore, 1985; Hughes & Church, 1986; 
Leoutsakos & Pearce, 1986; Lohse et al., 1987). The 
latter data suggest that the effects of adenosine on 
mast cell release are not mediated via typical aden-
osine receptors. Since adenosine uptake blockers 
prevent the Stimulation of mast cell histamine release 
by adenosine (Lohse et al., 1987) it is reasonable to 
assume that these effects are mediated via an intra-
cellular site. We have suggested that the action of 
adenosine at this site results in an enhanced sensi-
tivity of the release process to calcium (Lohse et al., 
1988). 
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In the present study we have investigated the 
relationship between the effects of calcium-
mobilizing agents and adenosinein order to charac-
terize further the site at which adenosine exerts its 
stimulatory effects on histamine release from rat 
peritoneal mast cells. 
Methods 
Preparation of mast cells 
Rat peritoneal mast cells from male Wistar rats were 
obtained by peritoneal lavage with HEPES-buffered 
saline (washing buffer) containing (mM): NaCI 137, 
KCI 2.7, NaH1P04 0.4, HEPES 10, glucose 5.5 and 
0.05% bovine serum albumin, pH 7.4 (adjusted with 
NaOH). All subsequent steps were carried out at 
4°C. The cell suspension was filtered through a 
250 pm nylon mesh, and the filtrate centrifuged for 
Smin at 120g. The pellet was resuspended in the 
original volume washing buffer and centrifuged as 
above. This washing step was repeated once and the 
cells resuspended in incubation buffer ( = washing 
buffer supplemented with 1 p.M CaC11 and 0.5 mM 
MgCI2), giving a suspension of about 2 x 105 mast 
cells per ml. It has been shown previously that the 
effects of adenosine on histamine release are indistin-
guishable in crude mast cell preparations and in cells 
purified to >95% homogeneity (Lohse et al., 1987; 
1988). 
Determination of histamine release 
Approximately 80,000 cells were preincubated at 
37°C for 10 min in 0.95 ml of incubation buffer 
together with the compounds to be investigated. 
This preincubation time was found to result in an 
optimal stimulation of release by adenosine ana-
logues. The rdease was initiated by addition of 50 p.l 
of incubation buffer containing either the calcium 
ionophore A23187 (0.1-0.4 JLM final concentration) or 
the Ieetin concana valin A ( 100 pg ml- 1 ). 
The reaction was stopped after 10 min by placing 
a 900 pl aliquot on ice, followed by centrifugation at 
200g for 10min at 0°C. The histamine content of 
both the supernatant and the pellet containing the 
cells were detennined by the ftuorometric method of 
Shore et al. (1959), as modified by Anton & Sayre 
(1969) and May et al. (1971). Histamine release was 
expressed as a percentage of the total histamine 
content (cells + medium). 
Data analysis 
Concentration-response data were analyzed by non-
linear nonweighted regression using a general form 
of the Hill-equation (Lohse et al., 1986): 
E- E E [Lr 
- b + max EC~o + [L]n (I) 
providing parameter estimates for E, effect; Eb, basal 
effect; Emax, maximal effect of agent; n, Hill coeßi-
cient; and [L] Iigand concentration. Results of indi-
vidual concentrations are presented as means, or 
means ± s.e.means. 
Materials 
The ionophore A23187, the adenosine uptake 
blocker S-(p-nitrobenzyl)-6-thioinosine (NBTI), 
adenosine and histamine were purchased from 
Sigma, München, Concanavalin A and HAM-FlO 
medium were obtained from Serva, Heidelberg, and 
orthophthaldialdehyde from Merck, Darmstadt 
5'-N-ethylcarboxamido-adenosine (NECA) was a gift 
from Byk Gulden, Konstanz. All. other drugs were of 
analytical grade. 
Results 
Wehave previously suggested that adenosine and its 
metabolically stable analogues increase histamine 
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Figure 1 Effect of N-ethylcarboxamidoadenosine 
(NECA) on the bistamine release from mast cells 
induced by various concentrations of A23187. Hista-
mine release was induced by the indicated concentra-
tions of A23187 in the absence ( 0) or presence ( e) of 
10 pM NECA and in the presence of 1.0 mM free extra-
cellular calcium. EC50 values (and 95% confidence 
Iimits) were: 0.34 pM (0.32-().37) under control condi-
tions and 0.26 pM (0.24-0.28) in the presence of NECA. 
Points show means of four experiments with duplicate 
samples; s.e.means shown by verticallines. 
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Figure Z Enhancement of the A23187-induced hista-
mine release by various concentrations of adenosine 
and N-ethylcarboxamidoadenosine (NECA). Histamin"' 
release was induced by 0.35 pM A23187 in the presence 
of the indicated concentrations of NECA (Ä) or aden-
osine <•>· EC50 values calculated from the averaged 
curves were 0.2 pM for NECA and l.lpM for adenosine. 
Slope factors were 0.6 for both oompounds. Points are 
means of eight experiments with duplicate samples, 
s.e.means shown by verticallines. 
release from rat peritoneal mast cells initiated by 
calcium-mobilizing agents by sensitizing the release 
process to calcium (Lohse et al., 1988). Figure 1 
demonstrates this for the calcium ionophore A23187. 
The presence of a maximally effective concentration 
of the adenosine analogue NECA (10 pM) shifted the 
concentration-response curve of A23187 to lower 
concentrations, changing the EC50 value from 
0.34 pM to 0.26JtM. In the presence and absence of 
NECA the concentratio~-response curves were very 
steep with slope factors of 4.6 (control) and 5.3 
(10 J'M NECA). NECA had no significant effect on 
the release in the absence of A23187. 
Figure 2 shows the concentration-response curves 
of adenosine and NECA in enhancing A23187-
induced histamine release. Both compounds have 
shallow curves with slopes significantly less than 1, 
when a large number of experiments is averaged. 
One possible explanation for such shallow 
concentration-response curves is that they result 
from the averaging of a heterogeneaus population of 
curves. Such heterogeneity of the concentration-
response curves has been observed for agents that 
inhibit histamine release from basophils by increas-
ing adenosine 3': 5' -cyclic monophosphate (cyclic 
AMP). The inhibitory effects of these agents are 
strongly dependent on the Ievel of stimulated release: 
the higher the release, the lower the inhibition 
obtained by these agents (Tung & Lichtenstein, 
1981). In order to examine whether a similar depen-
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Figure 3 Effects of N-ethylcarboxamidoadenosine 
(NECA) on the histamine release from mast cells at dif-
ferent degrees of stimulation by A23187. Histamine 
release was measured in the presence of 0.3 ( e ), 0.35 
<•> or 0.4 <•> pM A23187. Each curve is the mean of 
two experiments with duplicate samples. (a) Release 
expressed in % of total histamine content. (b) Release 
normalized to the E .... of the individual curve. The cal-
culated values of prestimulated release (EJ and EC50 
were: 0.3pM A23187: E., = 11.1%, EC50 = 930nM; 
0.35pM A23187: Eb = 29.5%, EC50 = 215nM; 0.4pM 
A23187: Eb = 38.5%, EC50 = 57nM. 
dence exists for the enhancing effects of adenosine 
analogues we investigated their effects at different 
Ievels of A23187-stimulated histamine release. 
Figure 3a shows the concentration-response 
curves of NECA in enhancing the histamine release 
induced by 0.3, 0.35 and 0.4pM A23187. A higher 
Ievel of stimulation markedly reduced the EC50 
value of NECA, which is most clearly seen when the 
curves are normalized to their respective Emall values 
(Figure 3b). lncreasing the Ievel of A23187-induced 
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Figure 4 Dependence of the EC50 value of adenosine 
in enhancing mast cell histamine release on the degree 
of Stimulation in the absence of adenosine. Histamine 
release was induced by different concentrations of 
A23187 (e) or Concanavalin A (0) in the presence of 
various concentrations of adenosine. Concentration-
response curves of the adenosine-induced enhancement 
of histamine release were analyzed as in Figure 3, giving 
EC50 values and Eb values ( = the release induced by 
A23187 or Concanavalin A alone). Shown is a plot of 
the EC50 values vs. the Eb values (%Stimulation). Each 
point is the EC50 value of one experiment with dupli-
cate samples. 
release from 10% to 35% of the total histamine 
content resulted in a 15 fold lower EC50 value of 
NECA in enhancing this release. Thus, it appears 
that stronger stimulation increases the sensitivity to 
NECA. 
This effect was also seen with adenosine itself: 
Figure 4 shows a plot of the EC50 values of aden-
osine in enhancing histamine release versus the Ievel 
of release induced by either A23187 or Concanavalin 
A. The EC50 values were derived from experiments 
analogous to those shown in Figure 3 for NECA. 
Again, the potency of adenosine increases when the 
release induced by A23187 alone increases. There is a 
concave relationship, with EC50 values ranging from 
0.5 JLM to 16 JLM. An apparently identical relationship 
was found for Concanavalin A-induced release, 
although higher Ievels of release could only be 
achieved with A23187. 
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Figure S Effects of S-(p-nitrobenzyl)-6-thioinosine 
(NBTI) on adenosine-stimulation of mast cell histamine 
release. Histamine release was measured in the absence 
( 0) or presence ( e) of 1 pM NBTI and the presence of 
0.3 pM (bottom curves) or 0.4 pM (top curves) of A23187. 
Data are the means of two experiments with duplicate 
samples for each concentration of A23187. 
We have previously shown that exogenous aden-
osine has to be taken up via the nucleoside trans-
porter in order to enhance mast cell mediator release 
(Lohse et al., 1987). Because the nucleoside transport 
is a facilitated bidirectional process, the presence of 
nucleoside transport inhibitors traps intracellular 
adenosine (Paterson et al., 1983). Therefore, if high 
Ievels of Stimulation sensitize mast cell histamine 
release to adenosine, the effects of the nucleoside 
transport inhibitor NBTI might be different at 
higher Ievels of release. lndeed, Figure 5 shows that 
in the absence of exogenaus adenosine, NBTI 1 JlM 
alone bad no effect at low Ievels of histamine release. 
However, NBTI markedly enhanced the release at a 
high Ievel of A23187-induced release. NBTI almost 
completely abolished the enhancing effect of exo-
genaus adenosine at either Ievel of prestimulation. 
Figure 6 shows the dependence of the enl\ancing 
effect of NBTI on the degree of stimulation of hista-
mine release induced by various concentrations of 
A23187. There was little enhancement by NBTI 
when the histamine release induced by A23187 alone 
was below 10%, but a marked effect was observed at 
higher Ievels of release, reaching a maximum when 
the A23187-induced release exceeded 20o/o. This 
relationship is very similar to that seen for the EC50 
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Figure 6 Dependence of the effect of ~nitrobenzyl)-
6-thioinosine (NBTI) on mast cell histamine release on 
the stimulated release. The release was stimulated in the 
absence or presence of 1 pM NBTI with different con-
centrations of A23187 as in Figure S. Plotted is the 
enhancement induced by NBTI as a function of the 
release in the presence of A23187 alone. Each point rep-
resents one experiment with duplicate samples. 
value of adenosine (Figure 4), suggesting that it 
reftects the same underlying mechanism. 
Discussion 
Adenosine and several of its metabolically stable 
analogues, such as NECA, appear to stimulate hista-
mine secretion from rat peritoneal mast cells by a 
mechanism distinct from Stimulation of A2 receptors 
and elevation of cyclic AMP. The inhibition of this 
effect by the nucleoside transport inhibitor NBTI 
suggests that elevation of intracellular adenosine is 
required (Lohse et al., 1987). The enhancement of 
histamine release appears to be related to an 
enhanced sensitivity of the release process to free 
intracellular calcium (Lohs~ et al., 1988). This 
enhanced sensitivity was seen in the present study as 
a shüt of the · concentration-response curve of the 
calcium ionophore A23187 to lower concentrations 
in the presence of NECA. 
Tung & Lichtenstein (1981) have demonstrated 
that l}asophils are more sensitive to inhibitory 
stimuli at low Ievels of release. Our data show that 
the reverse is true for the enhancing effects of aden-
osine: the potencies of adenosine and its metaboli-
cally stable analogue NECA are markedly increased 
at higher Ievels of release. Thus, 100. nM NECA has 
almost no effect when the release is below 10% of the 
total histamine content, but the same concentration 
causes a more than half maximal enhancement when 
the release exceeds 40%. This dependence of the 
response to adenosine and its analogues on the Ievel 
of Stimulation is a likely explanation for the large 
variations of its EC50 value and the ftat concen-
tration-response curves when a )arge number of 
experiments are averaged, which has been found by 
various workers (Marquardt et al., 1978; Holgate et 
al., 1980; Welton & Simko 1980; Church et al., 
1986). 
There are several reports in the Iiterature that 
calcium may not alone be responsible for the medi-
ation of secretory responses (see Gomperts, 1986, 
and Penner, 1988, for reviews). Our data presented 
here andin previous papers (Lohse et al., 1987; 1988) 
suggest that intracellular adenosine might represent 
a factor which is required in addition to an elevation 
of intracellular calcium for release to occur. 
Although more complex models can be proposed, 
the observation of a reciprocal enhancement of the 
effects of adenosine and calcium is compatible with 
their action at the same or closely related sites. This 
supports our assumption that the effects of aden-
osine are mediatedvia an intracellular site. However, 
other authors assume that adenosine acts on an 
atypical cell surface receptor on mast cells (Church 
et al., 1986; Marquardt et al., 1988). Our hypothesis 
was based mainly on the observations that the 
potent nucleoside transport inhibitors NBTI and 
S-(p-nitrobenzyl)-6-thioguanosine (NBT9) virtually 
abolish the enhancement of histamine release by 
adenosine. Although other nucleoside transport 
inhibitors such as dipyridamole ha ve been found to 
be inactive in this respect, this may be explained by 
their well-known low potency in the rat (Lohse et al., 
1987). It might be speculated that NBTI and NBTG 
act as antagonists at an atypical adenosine receptor 
on mast cells. Such a hypothesis is, however, incom-
patible with the observation that at high Ievels of 
release NBTI, while still blocking the effects Qf exo-
genaus adenosine, has an effect comparable ·to the 
maximal enhancement of adenosine, i.e. would 
appear to be a full agonist (see Figure 5). Conse- ' 
quently, we feel that an intracellular site of action of 
adenosine is the most sensible interpretation of our 
results. 
This intracellular site may be related to the 
GE-protein postulated by Gomperts and coworkers 
to link elevation of cytosolic free calcium and addi-
tional signals to exocytosis (Gomperts, 1986; Howell 
et al., 1987; Cockcroft et al., 1987). This hypothesis is 
also compatible with the observation that pretreat-
ment of hone marrow-derived mast cells with per-
, tussis toxin inhibits the enhancement of mediator 
release by adenosine (Marquardt & Walker, 1988), 
since pertussis toxin appears to affect the putative 
GE-protein (Penner, 1988). Finally, it has also been 
suggested that cyclic AMP exerts its inhibitory 
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effects on mediator release at the Ievel ofGE (Penner, 
1988). According to this hypothesis there may be an 
integration of several stimulatory and inhibitory 
intracellular signals at the Ievel of GE . Whereas the 
inhibitory effects of cyclic AMP are reduced in the 
face of strong stimuli (Tung & Lichtenstein, 1981), 
this paper shows that stimulatory signals may syner-
gistically enhance each other. 
Thus, intracellular adenosine and calcium may 
have synergistic effects on histamine release, by 
reciprocally increasing the sensitivity of the secretory 
process to the other agent. The data presented here 
show that physiological intracellular concentrations 
of adenosine are sufficient to produce these effects: 
first, trapping adenosine inside stimulated mast cells 
with NBTI can cause a considerable enhancement of 
histamine release, which corresponds to the effect 
produced by 1-3 JlM exogenous adenosine in the 
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